论文信息 - Long‐term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ‐I and TOPAZ‐II trials - 字舞流文

Long‐term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ‐I and TOPAZ‐II trials

R. Marinho | D. Dieterich | Armando Carvalho | M. Charafeddine | M. Bondin | P. Cacoub | D. Cohen | F. Poordad | A. Siddique | R. E. Castro | Armen Asatryan | F. Felizarta | Yiran B. Hu | H. Aguilar | N. Khan | A. Asatryan